Ongkeko WM - Search Results

1

Recombinant human erythropoietin promotes the acquisition of a malignant phenotype in head and neck squamous cell carcinoma cell lines in vitro.

Abhold E, Rahimy E, Wang-Rodriguez J, Blair KJ, Yu MA, Brumund KT, Weisman RA, Ongkeko WM. Abhold E, et al. Among authors: ongkeko wm. BMC Res Notes. 2011 Dec 21;4:553. doi: 10.1186/1756-0500-4-553. BMC Res Notes. 2011. PMID: 22188703 Free PMC article.

2

[Immunohistochemistry study of EGFR expression in head and neck squamous cell carcinoma].

Altuna Mariezkurrena X, Algaba Guimerá J, Wang Rodríguez J, Weisman R, Ongkeko W. Altuna Mariezkurrena X, et al. Acta Otorrinolaringol Esp. 2005 Apr;56(4):143-6. doi: 10.1016/s0001-6519(05)78589-7. Acta Otorrinolaringol Esp. 2005. PMID: 15871288 Free article. Spanish.

3

Expression of protein tyrosine kinases in head and neck squamous cell carcinomas.

Ongkeko WM, Altuna X, Weisman RA, Wang-Rodriguez J. Ongkeko WM, et al. Am J Clin Pathol. 2005 Jul;124(1):71-6. doi: 10.1309/BTLN5WTMJ3PCNRRC. Am J Clin Pathol. 2005. PMID: 15923166

4

EGFR regulates the side population in head and neck squamous cell carcinoma.

Chen JS, Pardo FS, Wang-Rodriguez J, Chu TS, Lopez JP, Aguilera J, Altuna X, Weisman RA, Ongkeko WM. Chen JS, et al. Among authors: ongkeko wm. Laryngoscope. 2006 Mar;116(3):401-6. doi: 10.1097/01.mlg.0000195075.14093.fb. Laryngoscope. 2006. PMID: 16540898

5

Gleevec suppresses p63 expression in head and neck squamous cell carcinoma despite p63 activation by DNA-damaging agents.

Ongkeko WM, An Y, Chu TS, Aguilera J, Dang CL, Wang-Rodriguez J. Ongkeko WM, et al. Laryngoscope. 2006 Aug;116(8):1390-6. doi: 10.1097/01.mlg.0000225941.60901.0f. Laryngoscope. 2006. PMID: 16885742

6

STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro.

Wang-Rodriguez J, Lopez JP, Altuna X, Chu TS, Weisman RA, Ongkeko WM. Wang-Rodriguez J, et al. Among authors: ongkeko wm. Laryngoscope. 2006 Aug;116(8):1409-16. doi: 10.1097/01.mlg.0000225895.40732.52. Laryngoscope. 2006. PMID: 16885745

7

Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.

Lopez JP, Wang-Rodriguez J, Chang C, Chen JS, Pardo FS, Aguilera J, Ongkeko WM. Lopez JP, et al. Among authors: ongkeko wm. Arch Otolaryngol Head Neck Surg. 2007 Oct;133(10):1022-7. doi: 10.1001/archotol.133.10.1022. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17938326

8

Gefitinib (Iressa) potentiates the effect of ionizing radiation in thyroid cancer cell lines.

Lopez JP, Wang-Rodriguez J, Chang CY, Sneh G, Yu MA, Pardo FS, Aguilera J, Ongkeko WM. Lopez JP, et al. Among authors: ongkeko wm. Laryngoscope. 2008 Aug;118(8):1372-6. doi: 10.1097/MLG.0b013e318172aae4. Laryngoscope. 2008. PMID: 18475209

9

Imatinib-mediated inactivation of Akt regulates ABCG2 function in head and neck squamous cell carcinoma.

Chu TS, Chen JS, Lopez JP, Pardo FS, Aguilera J, Ongkeko WM. Chu TS, et al. Among authors: ongkeko wm. Arch Otolaryngol Head Neck Surg. 2008 Sep;134(9):979-84. doi: 10.1001/archotol.134.9.979. Arch Otolaryngol Head Neck Surg. 2008. PMID: 18794444

10

p73 expression and function in vestibular schwannoma.

Ahmad ZK, Altuna X, Lopez JP, An Y, Wang-Rodriguez J, Juneja VR, Chen JS, Arandazi MJ, Aguilera J, Harris JP, Ongkeko WM. Ahmad ZK, et al. Among authors: ongkeko wm. Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):662-9. doi: 10.1001/archoto.2009.79. Arch Otolaryngol Head Neck Surg. 2009. PMID: 19620587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters